Mattu's Tax Loss Picks

[Ruellit]

PCHM

PharmChem, Inc. is an independent laboratory providing integrated drug testing services to corporate and governmental clients. For the 9 months ended 9/30/02, net sales decreased 20% to $22.9M. Net loss from continuing operations decreased 84% to $1.3M. Revenues reflect a decrease in laboratory analysis sales. Net loss reflects the absence of a $1M restructuring charge and a higher gross profit due to operating efficiencies.

 
                        
 Price                            $ 0.21 
  
 52 Week High                     $ 0.88  
  
 52 Week Low                      $ 0.07  
  
 3 Month Avg Daily Vol (Mil)        0.02  
  
 Beta                               0.50  
  
 Market Cap (Mil)                 $ 1.76  
  
 Shares Outstanding (Mil)           5.85  
  
 Float (Mil)                        5.60  
  
 Indicated Annual Dividend        $ 0.00  
  
 Dividend Yield %                   0.30  
  
 NA   EPS (TTM)                   $-0.32 
  
 P/E Ratio (TTM)                      NM 
  
 Book Value (MRQ)                 $ 1.76 
  
 Price/Book (MRQ)                   0.17 
  
 Sales Per Share (TTM)            $ 5.62 
  
 Return on Assets (TTM)          % -7.15  
  
 Return on Equity (TTM) %         -20.14 
  
 Cash Per Share (MRQ)             $ 0.71 
  
 Current Ratio (MRQ)                0.85 
  
 Total Debt/Equity (MRQ)           -0.70 
 

http://www.dbc.com/cgi-bin/htx.exe/squote?SOURCE=blq/ask&Ticker=PCHM&format=fraction&tab...